CTHRC1 and ovarian carcinoma: This indicates that CTHRC1 not only recruits macrophages but also reprograms them into an immunosuppressive M2 state, which supports cancer metastasis, making CTHRC1 a potential therapeutic target for disrupting this pro-tumorigenic interaction in ovarian cancer (59).